TheTriangle

[NWriter]

Promising Treatment Outcome for COV19 in RGC's report!

Regencell Bioscience Limited is a Hong Kong company which is fronting the uses of Traditional Chinese Medicine (”TCM”) to treat not only ADHD and ASD but also Covid-19 which shook the world back in 2020.

Regencell is currently a listed Company in NASDAQ market in the US with its ticker $RGC.

RGC was listed on July 21’ and has seen a rocket rise in share price over 300% weeks after its listing.

Based on BioSpectrum, RGC has treatment formula has test treated 19 patients (suspected or confirmed COVID cases). 12 of 19 patients which were treated exhibited improvements in their recovery after an average treatment period of 5 days.

[https://www.biospectrumasia.com/news/48/18957/regencell-bio-to-offer-traditional-medicines-for-covid-19-treatment-in-asean-countries.html]

In latest findings, for over a year (Mar 2020 - Aug 2021), RGC has established protocols and procedures for conducting Evaluation and Assessment of RGC-COV19 TCM through a Holistic approach **(EARTH)** efficacy trial in Malaysia and the United States.

The first EARTH effacacy trial (EARTH-A TRIAL) showned promising results which showned mild-moderate symtomps eliminated (except for Sensory Dysfunctional or occasional cough) on 97.3% of patients tested of the 37 patients gathered. EARTH-A TRIAL was conducted with the DELTA Variant.

Additional effecacy trial (EARTH-B TRIAL) was also conducted later, followed the same procedures as its predecessor effecacy trial but on a larger scale patient scale. In this trial, 80% of the COVID-19 cases were of Omicron variant for patients gathered in Malaysia.

Of the 51 Patients tested during EARTH-B Trial, 94.1% of the patients (48 patients) had sympstoms of mild-moderated eliminated (except for Sensory Dysfunction or occasional cough) within 6 days; whereas 90.2% (46 patients) had reported recovery of one or more symptons after one day of treatment. This report showned significant responses to the treatment compared to EARTH-A Trials.

In short, majority of the patients were reported to have eliminated all symptons (except Sensory Dysfunctional and Occasional Cough) after 3.6 days of starting treatment.

[https://finance.yahoo.com/news/rgc-second-investigational-study-rgc-094600752.html](https://finance.yahoo.com/news/rgc-second-investigational-study-rgc-094600752.html)